Baylor College of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Baylor College of Medicine sits in the top decile of US sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count).
Baylor College of Medicine: 616 sponsored US clinical trials, 93 recruiting.
Baylor College of Medicine sponsors 616 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 376 completed. 59 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Non-Hodgkin Lymphoma, with 7 trials.
Top-decile sponsor footprint
Baylor College of Medicine ranks in the top decile of sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
376 of 452 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
616 total, page 13 of 13
T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts
NCT00368355
Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)
NCT00058591
Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine
NCT00058799
Stem Cell Transplant to Treat Patients With Systemic Sclerosis
NCT00058578
High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis
NCT00040482
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program
NCT00138294
Treatments for Benign Paroxysmal Positional Vertigo (BPPV)
NCT00000359
Study of Irinotecan on a Weekly Schedule in Children
NCT00062842
Vector Delivery of the IL-12 Gene in Men With Prostate Cancer
NCT00406939
Valacyclovir in Immunocompromised Children
NCT00059592
Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL
NCT01713439
Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma
NCT00062855
Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL
NCT00058617
Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease
NCT00058773
Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
NCT00058812
Intrathecal Mafosfamide
NCT00062881
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 173 |
| Phase 2 | 59 |
| Phase 3 | 13 |
| Phase 4 | 46 |
Therapeutic Areas
What is open in the Baylor College of Medicine pipeline
93 recruiting of 616 indexed (15% open); 376 completed (61%).
Phase mix: 59 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Non-Hodgkin Lymphoma (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Baylor College of Medicine: open-pipeline peers nationwide
Peers matched on 616 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 616 trials (± recruiting share)
- University of Southern California · 617 trials · 16% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Stanford University · 15% recruiting · 1,744 trials
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- 59th Medical Wing · 15% recruiting · 20 trials
Related
What to do with this Baylor College of Medicine page
616 registered trials is a research-attention snapshot, not an endorsement of Baylor College of Medicine or any single study.
- 93 of Baylor College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Non-Hodgkin Lymphoma is the condition Baylor College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-Hodgkin Lymphoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor College of Medicine pipeline card: 616 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.